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Abstract 
Herein we report the first X-ray crystal structure of the well-known (S)-L-ala-Ni-BPB complex 
(1) and compare this with the X-ray crystal structures obtained for two novel fluorinated (S)-
L-ala-Ni-BPB complexes (8 and 12) that contain either an S- or R-fluorine atom on the proline 
ring of the BPB ligand. The preparation of complexes 8 and 12 has been enabled by the 
synthesis of two new fluorinated BPB ligands (7 and 11). In this work we looked to observe 
structural effects that the introduction of a single fluorine atom has on the known complex 1. 
Arising from this, we highlight a novel fluorine – nickel interaction that may provide additional 
stabilisation to complex 8.   
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1. Introduction 
 
The introduction of a fluorine atom in to a molecule can have a remarkable effect on its physical 
and chemical properties, metabolic stability and its biological activity. This has been widely 
exploited within medicinal chemistry and is discussed in detail in a number of recent review 
articles [1]. Fluorine substitution can also be used to fine-tune the stereo-electronic properties 
of a molecule and in doing so allow conformational control [2,3]. For example -fluoro imines 
have been shown by X-ray crystallographic analysis and theoretical DFT calculations, to have 
a torsion angle (ɸ) of approximately 60° about the NCCF bonds (Figure 1), therefore, 
preferentially adopting a gauche conformation [4]. This is explained by firstly, the avoidance 
of an electronically destabilising anti-arrangement around the NCCF bond (Figure 1), in which 
the electron-withdrawing fluorine atom lies directly opposite to the electron deficient imine or 
ammonium group. Secondly, the favoured conformation puts a hydrogen atom anti- to the 
imminium or ammonium group, thus allowing a stabilising electron-donation from C-H to *C-
N
+ by hyperconjugation (Figure 1). This has been utilised as a tool in medicinal chemistry, 
where introduction of a single fluorine atom with the correct stereochemistry selectively 
stabilises a compound in a biologically active conformation e.g. 3-fluoro-N-methyl-D-aspartic 
acid, whereas, the opposite enantiomer stabilises an inactive conformer [5]. Furthermore, 4-
fluoroprolines have been incorporated in to collagen triple helices with the observation that 
this modification confers hyperstability within these structures due to the above 
stereoelectronic effects [6]. A similar approach using fluoropyrrolidine derivatives (Figure 1) 
has also been pioneered recently by the Gilmour group as a method to control molecular 
conformation in acyclic systems, and thus, probe catalyst mechanism, reactivity and selectivity 
in asymmetric organocatalysis [7].  
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Figure 1 – Fluorine-ammonium gauche effect in 5-membered nitrogen-containing 
heterocycles [6]. 
 
Nickel (II) Schiff base complexes of (S)-2-[N-(N′-benzylprolyl)amino]benzophenone (BPB) 
and amino acids (e.g. 1) have been widely used as nucleophilic glycine equivalents in the 
asymmetric synthesis of C-substituted amino acids[8]. Soloshonok et al have also investigated 
the modification of the chelating ligand, replacing the proline ring in 1 to prepare novel NH-
Ni ligands and observing the resulting disatereomeric ratio of the Ni-complexes and the 
consequences in alkylation and Michael addition reactions [9, 10]. Incorporation of fluorine at 
the 3-position of protonated pyrrolidines has been shown to stabilise particular conformations 
through -fluoro-ammonium interactions [11]. In light of this we hypothesised that 
incorporation of a single fluorine atom on the proline ring within the BPB ligand could offer a 
novel route to modulate the conformation and hence the reactivity of a BPB-nickel (II) type 
complex. As such, we sought to probe whether the introduction of a fluorine atom in the correct 
configuration at the carbon beta to the proline nitrogen atom in 1 could invoke conformational 
effects, such as a fluorine-ammonium ion gauche effect, leading to complexes with an altered 
chelate ring configuration around the nickel atom.  
 
 
Here we report the synthesis and the first ever X-ray crystal structure of the well-known (S)-L-
Ala-Ni-BPB Schiff base complex (1). This structure has been compared with the X-ray crystal 
structures obtained for two novel fluorinated (S)-L-Ala-Ni-BPB complexes (8 and 12) that 
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contain either an S- or R-fluorine atom on the proline ring of the BPB ligand. The preparation 
of complexes 8 and 12 has been enabled by the synthesis of two new fluorinated BPB ligands 
(7 and 11). Furthermore, we highlight a novel Ni-F interaction and use DFT calculations to 
support a role for this in stabilizing the complex configuration. 
 
2. Results and discussion 
 
We initially prepared the reported (S)-BPB ligand [12] and corresponding (S)-L-Ala-Ni-BPB 
complex (1) [13] according to the published methods and obtained crystals of 1 by slow 
evaporation from acetone and methylethylketone. This was to provide a comparison of the 
overall structure of 1 with the fluorinated derivatives in X-ray diffraction studies (Figure 2). In 
spite of being synthesized and used many times by researchers in the field of peptide chemistry 
[14], the structure of complex (1) has not yet been reported in the literature (CCDC ver. 2013). 
Herein, we report the first X-ray structure of (S)-L-Ala-Ni-complex (1) (in form of MEK 
solvate).  
 
Figure 2. First reported X-ray crystal structure of (S)-L-Ala-Ni-BPB complex 1. The MEK 
solvent molecule and one of the component of disordered benzyl group are omitted for clarity. 
All crystal structure drawings were produced with Olex2 [15]. All structural images produced 
in Hermes [16]. 
 
We attempted to prepare the analogous R- and S- fluorinated nickel (II) complexes of the L- 
Schiff base of (S)-2-[N-(N′-benzylprolyl)amino]benzophenone (BPB) and L-alanine (7 and 12) 
starting from commercially available proline derivatives (Scheme 1 and Scheme 2, 
respectively). Trans-hydroxyproline methyl ester (trans-HypOMe, 2) was protected as the 
reported [17] N-(tert-butylcarbamate) (3) prior to a 2-step fluorination procedure employing 
tetrabutylammonium difluorotriphenylsilicate (TBAT) followed by treatment with perfluoro-
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1-butanesulfonyl fluoride (PBSF), with inversion of stereochemistry at the 4-position [18]. 
Removal of the Boc protecting group preceded N-benzylation using standard conditions. 
Conversion of the methyl ester (6) in to the required amide (7) was achieved directly through 
an oxidative process involving potassium tert-butoxide and exposure to atmospheric oxygen 
[19]. 
 
 
 
 
Scheme 1. Reagents and conditions: a) Boc2O, NEt3, CH2Cl2, rt, 18 h; b) i) TBAT, DIPEA, CH2Cl2, ii) PBSF, rt, 
72 h; c) TFA, CH2Cl2, rt, 2 h (used in next step without purification); d) benzyl bromide, K2CO3, DMF, rt, 20 h; 
e) 3-aminobenzophenone, tBuOK, THF, open to air, rt, 70 min. 
 
 
To prepare the alternative (R)-fluorinated ligand (Scheme 2), commercially sourced N-Boc-
trans-4-fluoro-L-proline (9) was deprotected by treatment with trifluoroacetic acid and used 
directly in an N-benzylation reaction without purification (Scheme 2) [20]. On this occasion, 
the free acid of 10 was coupled with 2-aminobenzophenone to afford amide 11 by initial 
conversion of the acid in to a mixed anhydride intermediate [21]. 
 
 
Scheme 2. Reagents and conditions: a) TFA, CH2Cl2, rt, 2 h (used in next step without purification); b) benzyl 
chloride, KOH, iPrOH, 50°C, 6 h; c) MsCl, 2-aminobenzophenone, Et3N, CH2Cl2.  
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With the fluorinated BPB ligands (7 and 11) in hand, we subsequently attempted to prepare the 
corresponding Ni-complexes (Scheme 3). Following the standard protocol for complexation 
with Ni(II), chiral ligand 7 was treated with nickel (II) nitrate hexahydrate and L-alanine under 
basic conditions with gentle heating. This reaction was performed in parallel with the 
analogous reaction to prepare the reported des-fluoro complex 1. After 2 h formation of 1 was 
complete and afforded a deep red solution. By comparison, more than 72 h were required for 
the (S)-fluorinated derivative (8) to reach completion. R-fluoro-BPB ligand 11, however, 
formed the desired Ni(II) complex (12) rapidly, within 20 min according to TLC, however, 
heating was continued for 24 h to ensure complete conversion. Crystals of complexes 8 and 12 
were obtained as dark red needles by slow evaporation from diethyl ether and the structures 
were determined by X-ray analysis. 
 
 
Scheme 3. Reagents and conditions: a) L-alanine, Ni(NO3)2.6H2O, MeOH, KOH, 60 °C, 24-72 h. 
 
It was proposed that, with the correct (S)-stereochemistry at the fluorine position, we would be 
able to stabilise the existing conformation by replacement of a hydrogen atom already 
orientated in the gauche conformation with respect to the nearby nickel-coordinating nitrogen 
atom (Figure 2).  
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Figure 3. X-ray crystal structure of L-Ala-Ni-(S)-FBPB complex 8. 
 
Figure 4. Least-squares superposition of fluorinated complex 8 (grey) with non-
fluorinated complex 1 (pink). 
 
The fluorinated and non-fluorinated complexes were aligned using the central nickel and its 
coordinated heteroatoms in molecular viewer Hermes [16] to an RMSD of less than 0.01 Å 
(Figure 3). The structure 8 contained two independent molecules with virtually identical 
configuration of the coordination polyhedron of metal atom. Overlay of 1 and 8 (Figure 4) 
showed that replacement of the corresponding gauche hydrogen with fluorine does not perturb 
the favoured conformation with respect to the benzyl group. We observed that the fluorine atom 
of 8 lies in the anticipated gauche conformation (Figure 5), with a measured NCCF bond 
torsion angle of 76° (slightly greater than 60° due to ring strain in the pyrrolidine) that is 
consistent with the corresponding non-fluorinated complex (1). 
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Figure 5. Expansion of a section of complex 8 showing the measured NCCF bond torsion 
angle of 76° and also displaying a putative C-H ··· F bond [Error! Bookmark not 
defined.]. 
 
Replacement of the hydrogen atom with fluorine introduces two further interesting 
intramolecular features in 8. Firstly, a putative intramolecular C-H ··· F bond may be observed 
(Figure 5). The existence of such interactions is controversial and many authors have concluded 
that any interaction may be only providing van der Waals stabilisation [22]. However, others 
have reported that despite being very weak non-covalent interactions, C-H ··· F interactions 
have been observed in organic structures, notably in some fluorobenzenes [23], and that these 
may be enhanced when the proton of the C-H bond is more acidic [24]. In complex 8 the 
fluorine atom is found to be within hydrogen bonding distance (2.64 Å) of the proximal methyl 
hydrogens (Figure 5). Although these are likely to be weak interactions, this could confer 
additional stability to the molecule. Secondly, as observed in the crystal structure, fluorine is 
positioned directly below the central nickel ion at a distance of 2.97 Å, which is smaller than 
the sum of their van der Waals radii (3.10 Å). As no alteration in the crystal structure of 8 is 
observed relative to the non-fluorinated compound 1 (Figure 4) e.g. due to repulsion between 
the F and Ni atoms, this may suggest that a non-bonding interaction arises, which may stabilise 
the complex.  
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Figure 6. Least squares superposition of complex 1 (pink) and complex 12 (green). 
 
Complex 12 was aligned to complex 1 as described above, to an RMSD of 0.05 Å. The greatest 
difference in the structures, as seen in Figure 6, is in the fluorinated proline ring. The position 
of the fluorine in complex 12 abolishes the potential nickel interaction observed in complex 8. 
Furthermore, the proline ring in complex 12 is twisted, where it is in the envelope conformation 
in complex 8 (Figure 7). A comparison of complex 12 with the CSD (version 5.35) using Mogul 
shows the torsions within this ring to be well represented, with the nearest comparable structure 
only 0.89° RMSD difference over ring torsions, and with 40% of the returned structures within 
10°. Finally, the NCCF torsion angle of complex 12 differs greatly from that of complex 8 
(Table 1, Figure 8), which is an expected change resulting from introduction of equatorial and 
axial substituents.  
 
 
 
Figure 7. The proline ring of complex 12 (green) is twisted, whereas the ring of complex 8 
(grey) adopts an envelope conformation.  
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Figure 8. The NCCF torsion angle of complex 12 is 152.4°. 
 
Table 1: Torsion angles for ΦNCCH and ΦNCCF. *For complex 1, NCCH2 angle is given as NCCF for 
comparison. 
Ni Complex ΦNCCH / ° ΦNCCF / ° 
1 -73.31 161.70* 
8 162.98 -75.97 
12 -86.23 152.36 
 
To investigate the differences between the complexes in more detail DFT, calculations were  
carried out using the crystal structures of complexes 8 and 12. By comparing the calculated 
energies of the R-fluorine and S-fluorine complexes it would be possible to estimate the 
strength of the interaction between S-fluorine and nickel. DFT calculations were performed as 
implemented in the Gaussian03 package. The B3LYP functional was used in conjunction with 
the 6-311 + +G** basis set. The difference in calculated energies between the two complexes 
(8 and 12) was determined to be 5.99 kJ/mol (in favour of the S-fluorine complex 8). This 
energy difference supports the notion of a stabilizing non-bonding interaction between the S-
fluorine and the nickel in complex 8 as observed in the X-ray structure. 
 
3. Conclusions 
Here we report the first X-ray crystal structure of the known nickel (II) Schiff base complex 
(1). This structure has been compared with the X-ray crystal structures obtained for two novel 
fluorinated nickel (II) Schiff base complexes that contain either an S- and R-fluorine atom beta 
to the proline nitrogen on the BPB ligand (8 and 12 respectively). We discovered that the 
introduction of an S-fluorine atom (complex 8) has no significant effect upon the overall 
structurally geometry of the complex. However, whilst we accept that these may be artifacts of 
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the structures being solved in the crystal form, we speculate that inclusion of a fluorine may 
enhance the conformational rigidity of complex 8 through a combination of the formation of a 
C-H ··· F bond and a novel Ni ··· F non-bonding interaction, as well as through a fluorine-
ammonium gauche interaction. DFT calculations also supported this hypothesis with a clear 
difference in the calculated energies of 5.99 kJ/mol between the S-fluorinated complex 8 and 
the R-fluorinated complex 12 (no Ni··· F interaction observed in the X-ray structure). 
Introduction of the R-fluorine atom substituent (complex 12) also afforded no significant 
overall changes to the structure although as expected some minor conformational changes in 
the proline ring of complex 12 were observed. Further investigations to probe any differences 
between complex 1 and the fluorinated complexes 8 and 12, with regard to reactivity and 
stability, are currently underway. 
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4. Experimental 
 
4.1 Materials 
L-4-trans-hydroxyproline methyl ester hydrochloride (2) (Novabiochem) and N-Boc-cis-4-
fluoro-L-proline methyl ester (9) (Sigma Aldrich) were purchased from commercial suppliers 
and used directly as indicated in the appropriate experimental procedures. All other chemicals 
were purchased from Sigma Aldrich. Complex 1 [Error! Bookmark not defined.] and 
intermediates 3 [17] and 4 [18] were prepared according to literature procedures and the 
obtained analytical data was in accordance with the published characterizations. The 
preparation of N-benzyl-(S)-4-fluoro-L-proline methyl ester (6) followed a previously 
undescribed route (details below) but analysis indicated that this was identical to the reported 
substance [19]. 
 
4.2 Characterization 
J. Fluorine Chem. 2014  
NMR spectra were collected using Bruker Avance 400 MHz or Varian VNMRS 700 MHz 
spectrometers. Multiplicities are reported as: s = singlet, d = doublet, m = multiplet, t = triplet 
or combinations thereof e.g. dd = doublet of doublets. Chemical shifts are reported in ppm and 
are referenced to residual solvent peaks; CHCl3 (
1H 7.26 ppm, 13C 77.2 ppm), H2O (
1H 4.79 
ppm). J couplings are measured in Hertz (Hz). Reactions were monitored by TLC using Merck 
precoated silica gel plates. Column chromatography was performed using silica gel with the 
solvent system indicated. All reported yields refer to the isolated yield and the product purity 
was estimated to be >95% by 1H NMR. IR spectra were recorded on a Perkin Elmer Spectrum 
RX1 fitted with an ATR attachment. IR absorptions reported are in cm-1. Mass spectra were 
collected on a Waters TQD mass spectrometer and accurate mass spectra were collected on a 
Waters LCT Premier XE mass spectrometer. Optical rotations were measured using a Jasco P-
1020 polarimeter with samples in the solvents, temperatures and concentrations as indicated. 
 
4.2.1 N-benzyl-(S)-4-fluoro-L-proline methyl ester (6) [19]. A solution of 4 (0.50 g, 2.00 
mmol) in CH2Cl2 (25 mL) and trifluoroacetic acid (2.5 mL) was stirred at room temperature 
for 2 h. Upon completion of the reaction, volatiles were removed under reduced pressure, 
affording a colourless solid (0.29 g, quant.). Trifluoroacetate salt 5 was used directly in the 
subsequent step without further purification. Potassium carbonate (1.47 g, 10.6 mmol) was 
added to a rapidly stirred suspension of 5 (0.55 g, 2.12 mmol) in anhydrous DMF (50 mL) and 
gradually reached homogeneity after 1 h at room temperature. Benzyl bromide was added in 
one portion and the reaction mixture was stirred for a further 48 h at room temperature until 
TLC indicated the complete consumption of starting materials. The crude mixture was poured 
over crushed ice and stirred until thawing was complete and the emulsion was extracted with 
Et2O (100 mL), which was then washed with brine (sat.) (3  30 mL). Purification by column 
chromatography (silica; EtOAc – hexane 0% to 50%) afforded the desired product (0.39 g, 
75%). All analyses were consistent with the reported preparation [25]. 
 
Pale yellow oil, 1H NMR (400 MHz, CDCl3): δ 7.35 – 7.22 (m, 5H, Ph), 5.08 (dm, J = 54.7 
Hz, 1H, CHF), 4.02 (d, J = 13.1 Hz, 1H, benzyl CH), 3.69 (s, 3H, OMe), 3.58 (d, J = 13.1 Hz, 
1H, benzyl CH), 3.33 – 3.20 (m, 2H, CH2), 2.63 – 2.42 (m, 2H, CH2), 2.27 (m, 1H, CH); 13C 
NMR (101 MHz, CDCl3): δ 172.2,  136.4, 128.1, 127.3, 126.3, 91.0 (d, JC-F = 173.2 Hz), 62.7, 
58.2 (d, JC-F = 22.1 Hz), 56.8, 51.0, 36.2 (d, JC-F = 22.1 Hz); 
19F NMR (376 MHz, CDCl3): δ -
168.99 (m, 1F); LCMS (ESI+) 238.09 [M+H]+. 
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4.2.2 (S)-2-[N-(N′-benzyl-(S)-4-fluoro-L-prolyl)amino]benzophenone (7). The methyl ester 
6 (0.26 g, 1.1 mmol) was added to a solution of tBuOK (0.25 g, 2.19 mmol) in moist THF (15 
mL), which was pre-stirred open to the air for 1 minute. Addition of 2-aminobenzophenone 
(0.22 g, 1.1 mmol). After stirring at room temperature for 1 h TLC indicated that the reaction 
was incomplete. Additional tBuOK (123 mg, 1.1 mmol) was added and again stirred for 1 h. 
The crude mixture was concentrated in vacuo and partitioned between CH2Cl2 (20 mL) and 
water (20 mL). The organic extract was dried (MgSO4) and concentrated to an oil. The title 
compound was isolated after column chromatography (silica; EtOAc – hexane 0% to 30%) (97 
mg, 22%) as a pale yellow oil.  
 
[∝]𝐷
23 – 41.1 (c = 1.0, CHCl3); 1H NMR (400 MHz, CDCl3): δ 11.61 (s, 1H, NH), 8.55 (d, J = 
8.3 Hz, 1H, Ar), 7.83 – 7.75 (m, 2H, Ar), 7.62 – 7.56 (m, 1H, Ar), 7.56 – 7.45 (m, 4H, Ar), 
7.45 – 7.38 (m, 2H, Ar), 7.22 – 7.15 (m, 3H, Ar), 7.09 (t, J = 7.6 Hz, 1H, Ar), 5.10 (dt, J = 
52.9, 4.1 Hz, 1H, CHF), 4.00 (d, J = 13.0 Hz, 1H, benzyl CH), 3.63 (d, J = 13.0 Hz, 1H, benzyl 
CH), 3.55 – 3.39 (m, 2H, CH), 2.70 – 2.43 (m, 2H, CH2), 2.31 (m, 1H, CFCH), 1.26 (s, 1H, 
CH); 13C NMR (101 MHz, CDCl3): δ 199.1, 172.2, 139.7, 139.0, 137.6, 133.5, 132.7, 128.3, 
127.5, 127.3, 126.2, 125.2, 121.7, 120.9, 92.2 (d, JC-F = 179.5 Hz), 62.4, 58.4 (d, JC-F = 22.0 
Hz), 57.0, 51.1, 36.6 (d, JC-F = 22.1 Hz); 
19F NMR (376 MHz, CDCl3): δ -172.11 (m, 1F); IR 
(neat)  3320, 2945, 1675, 1655, 1287, 1115, 703  cm-1; LCMS (ESI+) m/z = 403.19 [M+H]+. 
HRMS (ESI) calcd for C25H24FN2O2 [M+H]
+: m/z = 403.1812, found 403.1822. 
 
 
4.2.3 L-Ala-Ni-(S)-fluoro-BPB complex (8). To a solution of 7 (27 mg, 0.08 mmol) and 
Ni(NO3)26H2O (44 mg, 0.15 mmol) in anhydrous methanol (2 mL) was added a solution of 
KOH (34 mg, 0.60 mmol) and L-alanine (34 mg, 0.38 mmol) in methanol (1 mL). This mixture 
was heated at 60 °C with stirring for 72 h – TLC indicated the reaction was complete and the 
deep red solution concentrated in vacuo before partitioning between water (30 mL) and CHCl3 
(20 mL). Trituration of the concentrated organic extract under Et2O afforded a dark red solid 
that was isolated by filtration under suction and washed with more Et2O. Purification of the 
crude material by preparative TLC (silica; acetone – CHCl3 20%) afforded a red/orange solid 
(22 mg, 55%). 
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mp 288 – 290 °C (dec.); [∝]𝐷
23 + 255 (c = 2.0, CHCl3);
 1H NMR (700 MHz, CDCl3): δ 8.09 (d, 
J = 7.9 Hz, 3H, Ar), 7.54 – 7.47 (m, 2H, Ar), 7.47 – 7.42 (m, 1H, Ar), 7.38 (t, J = 7.7 Hz, 2H, 
Ar), 7.25 – 7.21 (m, 2H, Ar), 7.14 (ddd, J = 8.7, 6.9, 1.8 Hz, 1H, Ar), 6.97 (dm, J = 7.7 Hz, 
1H, Ar), 6.67 (m, 1H, Ar), 6.62 (dd, J = 7.7, 1.8 Hz, 1H, Ar), 5.49 (dm, J = 52.7 Hz, 1H, CHF), 
4.59 (d, J = 12.7 Hz, 1H, benzyl CH), 3.99 (m, 1H, CH), 3.90 (m, 1H, CH), 3.65 (dd, J = 11.6, 
4.7 Hz, 1H, CH), 3.58 (d, J = 12.7 Hz, 1H, benzyl CH), 2.91 (m, 1H, CH), 2.76 (m, 1H, CH), 
2.25 (ddd, J = 36.4, 11.6, 3.5 Hz, 1H, CH), 1.60 (m, 3H, CH3); 
13C NMR (101 MHz, CDCl3): 
δ 179.9, 170.1, 141.9, 133.4, 133.1, 132.6, 131.9, 131.7, 129.6, 129.2, 129.0, 128.8, 127.5, 
127.2, 126.7, 123.8, 120.8, 91.4 (d, J = 179.0 Hz), 68.6, 66.9, 62.9, 61.5 (d, J = 20.4 Hz), 38.4 
(d, J = 22.4 Hz), 20.3; 19F NMR (376 MHz, CDCl3): δ -167.18 (m, 1F); LCMS (ESI+) m/z = 
530.12 [M+H]+; HRMS (ESI) calcd for C28H27FN3O3Ni [M+H]
+: m/z = 530.1382, found 
530.1390. 
 
4.2.4 N-benzyl-(R)-4-fluoro-L-proline hydrochloride salt (10). A solution of N-Boc-(R)-4-
fluoro-L-proline (0.5 g, 2. 18 mmol) in CH2Cl2 (25 mL) and trifluoroacetic acid (2.5 mL) was 
stirred at room temperature for 2 h. Upon completion of the reaction, volatiles were removed 
under reduced pressure, affording a colourless solid (0.52 g, quant.). The trifluoroacetate salt 
was used directly in the subsequent step without further purification. A solution of the salt in 
isopropanol (5 mL) was added to a fully dissolved solution of potassium hydroxide (0.61 g, 
10.9 mmol) in isopropanol (25 mL), followed by dropwise addition of benzyl chloride (350 
µL, 3.1 mmol) with stirring at 50 °C for 6 h. The pH was adjusted to around 5 by addition of 
concentrated hydrochloric acid and extracted with CHCl3 (20 mL). Solids were removed by 
filtration and washed with CHCl3 (2 × 10 mL). The organic extracts were combined and 
concentrated in vacuo to a pale oil, which was triturated under cold acetone (20 mL) and the 
resulting analytically pure white solid was isolated by filtration and washed with more cold 
acetone (10 mL). Additional product was isolated from the acetone washings and was 
combined with the initial crop (0.37 g, 66%).  
 
mp 213 - 215 °C; [∝]𝐷
27 + 18.9 (c = 0.95, H2O);
 1H NMR (400 MHz, D2O): δ 7.49 – 7.34 (m, 
5H, Ph), 5.41 (dt, J = 51.7, 3.9 Hz, 1H, CHF), 4.54 – 4.38 (m, 3H, CH and benzyl CH2), 3.98 
– 3.63 (m, 2H, CH2), 2.78 (m, 1H, CH), 2.25 (dm, J = 39.3 Hz, 1H, CHF); 13C NMR (101 
MHz, D2O): δ 170.7, 130.7, 130.3, 129.3, 91.8 (d, JC-F = 171.7 Hz), 66.5, 60.6, 59.8 (d, JC-F = 
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21.7 Hz), 36.3 (d, JC-F = 21.7 Hz); 
19F NMR (376 MHz, D2O): δ -173.53 (m, 1F); IR (neat)  
3037, 2944, 1644, 1159 712 cm-1; LCMS (ESI+) 224.28 [M+H]+. 
 
4.2.5 (S)-2-[N-(N′-benzyl-(R)-4-fluoro-L-prolyl)amino]benzophenone (11). 
Methanesulfonyl chloride (105 µL, 1.36 mmol) was added slowly to a solution containing N-
methylimidazole (216 µL, 2.72 mmol) and proline acid 10 (0.28 g, 1.24 mmol) in CH2Cl2, 
cooled to 0°C. After stirring for 10 min, the flask was removed from the ice bath, and 2- 
aminobenzophenone (0.22 g, 1.12 mmol) was added and the reaction mixture was stirred at 50 
°C for 20 h. The reaction was quenched by addition of sat. NH4Cl aq. (10 mL), the organic 
phase was extracted CH2Cl2 (2 × 20 mL) and volatiles were removed under reduced pressure. 
The crude mixture was purified by column chromatography (silica; 1:9 ethyl acetate-hexane) 
and isolated as a pale brown oil (0.38 g, 76%).  
 
[∝]𝐷
24 −14.1 (c = 1, CHCl3); 1H NMR (400 MHz, CDCl3): δ 11.59 (s, 1H, NH), 8.59 (dd, J = 
8.4, 1.1 Hz, 1H, Ar), 7.81 – 7.74 (m, 2H, Ar), 7.65 – 7.59 (m, 1H, Ar), 7.58 – 7.47 (m, 4H, Ar), 
7.46 – 7.41 (m, 2H, Ar), 7.19 – 7.13 (m, 3H, Ar), 7.10 (ddd, J = 8.2, 7.3, 1.1 Hz, 1H, Ar), 5.35 
(dm, J = 52.0, Hz, 1H, CHF), 4.03 (d, J = 13.0 Hz, 1H, benzyl CH), 3.78 – 3.65 (m, 2H, CH 
and benzyl CH), 3.48 (ddd, J = 34.8, 13.1, 4.2 Hz, 1H, CH), 2.90 (ddt, J = 28.5, 13.0, 1.8 Hz, 
1H, CH), 2.72 – 2.55 (m, 1H, CH), 2.22 – 2.01 (m, 1H, CH); 13C NMR (101 MHz, CDCl3): δ 
198.3, 172.9, 139.2, 138.5, 137.9, 133.6, 132.8, 132.6, 130.1, 129.0, 128.4, 128.3, 127.3, 124.9, 
122.4, 121.6, 93.6 (d, JC-F = 180.1 Hz), 67.8, 60.6, 59.3 (d, JC-F  = 22.0 Hz,), 38.7 (d, JC-F  = 
22.1 Hz); 19F NMR (376 MHz, CDCl3): δ -171.49 (m, 1F); IR (neat)  3296, 1703, 1521, 1264, 
1169, 733 cm-1; LCMS (ESI+) m/z = 402.98 [M+H]+; HRMS (ESI) calcd for C25H24FN2O2 
[M+H]+: m/z = 403.1810, found 403.1822; 
 
 
4.2.6 L-Ala-Ni-(S)-fluoro-BPB complex (12). To a solution of 11 (0.10 g, 0.27 mmol) and 
Ni(NO3)26H2O (0.16 g, 0.55 mmol) in anhydrous methanol (3 mL) was added a solution of 
KOH (0.12 mg, 2.20 mmol) and L-alanine (0.12 g, 1.37 mmol) in methanol (2 mL). This 
mixture was heated at 60 °C with stirring for 24 h – TLC indicated the reaction was complete 
and the deep red solution concentrated in vacuo before partitioning between water (30 mL) and 
CHCl3 (20 mL). Trituration of the concentrated organic extract under Et2O afforded a dark red 
solid that was isolated by filtration under suction and washed with more Et2O. The washings 
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were combined and evaporated and triturated again to obtain further material, which was 
analytically pure without further purification (0.10 mg, 71%). 
 
mp 296 – 298 °C; [∝]𝐷
24 + 241 (c = 1.0, CHCl3);
 1H NMR (400 MHz, CDCl3): δ 8.28 – 8.22 
(m, 2H, Ar), 8.03 (dd, J = 8.7, 1.1 Hz, 1H, Ar), 7.55 – 7.47 (m, 2H, Ar), 7.47 – 7.41 (m, 1H, 
Ar), 7.38 (t, J = 7.7 Hz, 2H, Ar), 7.30 – 7.17 (m, 2H, Ar), 7.12 (ddd, J = 8.7, 6.8, 1.9 Hz, 1H, 
Ar), 6.96 – 6.90 (m, 1H, Ar), 6.70 – 6.59 (m, 2H, Ar), 5.68 (dm, J = 55.1 Hz, 1H, CHF), 4.42 
(d, J = 12.4 Hz, 1H, benzyl CH), 4.25 (ddd, J = 32.8, 14.4, 4.3 Hz, 1H, CH), 3.95 – 3.81 (m, 
2H, CH), 3.65 (d, J = 12.4 Hz, 1H, benzyl CH), 3.32 (dddd, J = 35.7, 15.1, 10.9, 4.5 Hz, 1H, 
CH), 2.94 (m, 2H, CH), 1.54 (d, J = 7.0 Hz, 3H, CH3); 
13C NMR (101 MHz, CDCl3): δ 180.4, 
178.9, 170.8, 142.0, 133.5, 133.4, 133.3, 132.4, 131.8, 129.9, 129.4, 129.1, 129.0, 127.6, 127.3, 
126.4, 123.8, 121.1, 91.4 (d, JC-F = 178.6 Hz), 70.1, 66.5, 65.5, 64.0 (d, JC-F  = 21.7 Hz), 39.4 
(d, JC-F  = 21.6 Hz), 21.8; 
19F NMR (376 MHz, CDCl3) δ -173.86 (m, 1F); LCMS (ESI+) m/z 
= 530.06 [M+H]+; HRMS (ESI) calcd for C28H27FN3O3Ni [M+H]
+: m/z = 530.1385, found 
530.1390. 
 
X-ray crystal structure determination and structural analysis 
 
The X-ray single crystal data have been collected on a Bruker SMART CCD 6000 (compound 
8, sealed fine-focus tube, graphite monochromator, λMoKα, λ =0.71073 Å) and D8Venture 
(compounds 1 and 12, IμS-microsource, focusing mirrors, Photon 100 CMOS detector, λCuKα, 
λ = 1.54178 Å and λMoKα, λ = 0.71073 Å, respectively,) diffractometers equipped with the 
Cryostream (Oxford Cryosystems) open-flow nitrogen cryostats at the temperature 120.0(2) K. 
All structures were solved by direct method and refined by full-matrix least squares on F2 for 
all data using Olex2 [15] and SHELXTL [26] software. All non-disordered non-hydrogen 
atoms were refined anisotropically, hydrogen atoms in structure 8 were refined isotropically. 
The atoms of disordered groups in structure 1 were refined with fixed SOF values in isotropic 
approximation. The hydrogen atoms in these groups and in the structures 1 and 12 were placed 
in the calculated positions and refined in riding mode.  
 
Crystal data for 1: C28H27N3NiO3 x C4H8O (M = 584.34), orthorhombic, space group P212121, 
a = 9.0963(2), b = 12.1090(3), c = 26.0025(6) Å, V = 2864.10(12) Å3, Z = 4, μ(CuKα) = 1.312 
mm-1, Dcalc = 1.355 g/mm
3, 21312 reflections measured, 5425 unique (Rint = 0.0260) were used 
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in all calculations. The final R1 was 0.0470 (5218 >2σ(I)) and wR2 was 0.1297 (all data), S = 
1.051. 
Crystal data for 8: C28H26N3O3FNi (M= 530.23): orthorhombic, space group P212121, a = 
9.4749(5), b = 11.3449(7), c = 44.685(3) Å, V = 4803.2(5) Å3, Z = 8, μ(MoKα)= 0.852 mm-1, 
Dcalc = 1.466 g/mm
3, 78710 reflections measured, 12765 unique (Rint = 0.0738) were used in 
all calculations. The final R1 was 0.0364 (10213 >2σ(I)) and wR2 was 0.0766 (all data), S = 
0.978. 
Crystal data for 12: C28H26N3O3FNi (M = 530.23): orthorhombic, space group P212121, a = 
9.6711(8), b = 10.0617(8), c = 24.6671(19) Å, V = 2400.3(3) Å3, Z = 4, μ(MoKα) = 0.853 mm-
1, Dcalc = 1.467 g/cm
3, 33745 reflections measured, 6370 unique (Rint = 0.0834) which were 
used in all calculations. The final R1 was 0.0584 (5748 >2σ(I)) and wR2 was 0.1369 (all data), 
S = 1.077. 
CCDC xxx,xxx and xxx contain the supplementary crystallographic data for this paper. These 
data can be viewed free of charge via http://www.ccdc.cam.ac.uk/cont/retrieving.html or from 
the CCDC, 12 Union Road, Cambridge, CB2 1EZ; fax: +44 1223 336033. E-mail: 
deposit@ccdc.cam.ac.uk  
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